106 related articles for article (PubMed ID: 3068033)
21. Mechanism for the reductive activation of diaziquone.
Mossoba MM; Alizadeh M; Gutierrez PL
J Pharm Sci; 1985 Dec; 74(12):1249-54. PubMed ID: 4087189
[TBL] [Abstract][Full Text] [Related]
22. DNA strand scission and cross-linking by diaziridinylbenzoquinone (diaziquone) in human cells and relation to cell killing.
Szmigiero L; Erickson LC; Ewig RA; Kohn KW
Cancer Res; 1984 Oct; 44(10):4447-52. PubMed ID: 6467204
[TBL] [Abstract][Full Text] [Related]
23. Thiol oxidation coupled to DT-diaphorase-catalysed reduction of diaziquone. Reductive and oxidative pathways of diaziquone semiquinone modulated by glutathione and superoxide dismutase.
Ordoñez ID; Cadenas E
Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):481-90. PubMed ID: 1530580
[TBL] [Abstract][Full Text] [Related]
24. The pharmacology of diaziquone given in intravenous or intracarotid infusion to normal and intracranial tumor-bearing puppies.
Egorin MJ; Bellis EH; Salcman M; Collins JM; Spiegel JF; Bachur NR
J Neurosurg; 1984 May; 60(5):1005-13. PubMed ID: 6716135
[TBL] [Abstract][Full Text] [Related]
25. Sister chromatid exchange induction by diaziquone in human and mouse lymphocytes following both in vivo and in vitro exposures.
Kligerman AD; Erexson GL; Bryant MF
Cancer Res; 1988 Jan; 48(1):27-31. PubMed ID: 3334997
[TBL] [Abstract][Full Text] [Related]
26. Reductive metabolism of diaziquone (AZQ) in the S9 fraction of MCF-7 cells. II. Enhancement of the alkylating activity of AZQ by NAD(P)H: quinone-acceptor oxidoreductase (DT-diaphorase).
Fisher GR; Donis J; Gutierrez PL
Biochem Pharmacol; 1992 Oct; 44(8):1625-35. PubMed ID: 1301071
[TBL] [Abstract][Full Text] [Related]
27. Trace detection of hydroxyl radicals during the redox cycling of low concentrations of diaziquone: a new approach.
Li B; Blough NV; Gutierrez PL
Free Radic Biol Med; 2000 Sep; 29(6):548-56. PubMed ID: 11025198
[TBL] [Abstract][Full Text] [Related]
28. Diaziquone as a potential agent for photoirradiation therapy: formation of the semiquinone and hydroxyl radicals by visible light.
Mossoba MM; Gutierrez PL
Biochem Biophys Res Commun; 1985 Oct; 132(1):445-52. PubMed ID: 2998365
[TBL] [Abstract][Full Text] [Related]
29. Relationship between ascorbyl radical intensity and apoptosis-inducing activity.
Sakagami H; Satoh K; Ohata H; Takahashi H; Yoshida H; Iida M; Kuribayashi N; Sakagami T; Momose K; Takeda M
Anticancer Res; 1996; 16(5A):2635-44. PubMed ID: 8917363
[TBL] [Abstract][Full Text] [Related]
30. Clinical pharmacology of 2,5'-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone (AZQ).
Lu K; Savaraj N; Yap BS; Bedikian AY; Feun L; Benjamin RS; Loo TL
Eur J Cancer Clin Oncol; 1983 May; 19(5):603-6. PubMed ID: 6683631
[TBL] [Abstract][Full Text] [Related]
31. Free radicals in quinone containing antitumor agents. The nature of the diaziquone (3,6,-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone) free radical.
Gutierrez PL; Bachur NR
Biochim Biophys Acta; 1983 Jul; 758(1):37-41. PubMed ID: 6305426
[TBL] [Abstract][Full Text] [Related]
32. The reduction of anti-tumour diaziridinyl benzoquinones.
Butler J; Hoey BM; Lea JS
Biochim Biophys Acta; 1987 Aug; 925(2):144-9. PubMed ID: 3040109
[TBL] [Abstract][Full Text] [Related]
33. Diaziquone, 2,5-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone, plasma and cerebrospinal fluid kinetics.
Bachur NR; Collins JM; Kelley JA; Van Echo DA; Kaplan RS; Whitacre M
Clin Pharmacol Ther; 1982 May; 31(5):650-5. PubMed ID: 7075113
[TBL] [Abstract][Full Text] [Related]
34. Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomas.
Greenberg HS; Ensminger WD; Layton PB; Gebarski S; Meyer M; Chaffee B; Bender JF; Grillo-Lopez AJ
Cancer Treat Rep; 1986 Mar; 70(3):353-7. PubMed ID: 3006913
[TBL] [Abstract][Full Text] [Related]
35. The lack of correlation between toxicity and free radical formation of two diaziridinyl benzoquinones.
Lea JS; Garner HJ; Butler J; Hoey BM; Ward TH
Biochem Pharmacol; 1988 May; 37(10):2023-5. PubMed ID: 2837220
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of diaziquone after three different dosage regimens.
Bjornsson TD; Schold SC; Friedman HS; Schneider D; Falletta JM
Cancer Treat Rep; 1985 Dec; 69(12):1383-5. PubMed ID: 4075314
[TBL] [Abstract][Full Text] [Related]
37. Free radicals in toxicology.
Aust SD; Chignell CF; Bray TM; Kalyanaraman B; Mason RP
Toxicol Appl Pharmacol; 1993 Jun; 120(2):168-78. PubMed ID: 8511786
[TBL] [Abstract][Full Text] [Related]
38. Continuous-infusion diaziquone in acute myeloid leukemia: a Southeastern Cancer Study Group trial.
Lyman GH; Vogler WR; Raney M
Cancer Treat Rep; 1987 Mar; 71(3):309-10. PubMed ID: 3545462
[TBL] [Abstract][Full Text] [Related]
39. Induction of p21 mediated by reactive oxygen species formed during the metabolism of aziridinylbenzoquinones by HCT116 cells.
Qiu X; Forman HJ; Schönthal AH; Cadenas E
J Biol Chem; 1996 Dec; 271(50):31915-21. PubMed ID: 8943236
[TBL] [Abstract][Full Text] [Related]
40. Photosensitization of leukemia L1210 cells with diaziquone.
Kessel D; Thompson P
Cancer Res; 1986 Nov; 46(11):5587-8. PubMed ID: 3756904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
